Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Inogen's operating assets for the quarter that ended in Dec. 2023 was $197.7 Mil. Inogen's operating liabilities for the quarter that ended in Dec. 2023 was $99.5 Mil. Inogen's Total Assets for the quarter that ended in Sep. 2023 was $343.7 Mil. Therefore, Inogen's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2023 was 0.29.
Inogen Scaled Net Operating Assets Historical Data
The historical data trend for Inogen's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
Inogen Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Scaled Net Operating Assets |
|
|
|
|
|
|
0.38 |
0.29 |
0.33 |
0.27 |
0.24 |
|
Inogen Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Scaled Net Operating Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.29 |
0.32 |
0.33 |
0.31 |
0.29 |
Competitive Comparison
For the Medical Devices subindustry, Inogen's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inogen Scaled Net Operating Assets Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Inogen's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Inogen's Scaled Net Operating Assets falls into.
Inogen Scaled Net Operating Assets Calculation
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Inogen's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as
| Scaled Net Operating Assets (SNOA) | | (A: Dec. 2023 ) |
| = | (Operating Assets (A: Dec. 2023 ) | - | Operating Liabilities (A: Dec. 2023 )) | / | Total Assets (A: Dec. 2022 ) |
| = | (197.723 | - | 99.459) | / | 405.041 |
| = | 0.24 |
where
Inogen's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2023 is calculated as
| Scaled Net Operating Assets (SNOA) | | (Q: Dec. 2023 ) |
| = | (Operating Assets (Q: Dec. 2023 ) | - | Operating Liabilities (Q: Dec. 2023 )) | / | Total Assets (Q: Sep. 2023 ) |
| = | (197.723 | - | 99.459) | / | 343.696 |
| = | 0.29 |
where
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inogen (Inogen) Business Description
Traded in Other Exchanges
Address
301 Coromar Drive, Goleta, CA, USA, 93117
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.
Executives
| Thomas A. West |
director |
C/O INTERSECT, INC., 1555 ADAMS DRIVE, MENLO PARK CA 94025 |
| Stanislav Glezer |
officer: EVP, Chief Medical Officer |
C/O INOGEN, INC., 326 BOLLAY DRIVE., GOLETA CA 93117 |
| Jason Somer |
officer: EVP, Gen. Counsel & Secretary |
C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA CA 93117 |
| Glenn S Boehnlein |
director |
2825 AIRVIEW BLVD, KALAMAZOO MI 49002 |
| Mary Kay Ladone |
director |
130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601 |
| Kevin M King |
director |
C/O AFFYMETRIX, INC., 3420 CENTRAL EXPRESSWAY, SANTA CLARA CA 95051 |
| Kristin A. Caltrider |
officer: EVP, CFO and Treasurer |
C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA CA 93117 |
| Anderson Ray Benjamin M |
director |
1100 NORTH WASHINGTON STREET, DELPHI IN 46923 |
| Michael K. Sergesketter |
officer: EVP, CFO and Treasurer |
301 COROMAR DRIVE, GOLETA CA 93117 |
| Raymond Huggenberger |
director, officer: See Remarks |
326 BOLLAY DRIVE, GOLETA CA 93117 |
| Alison Bauerlein |
officer: See Remarks |
326 BOLLAY DRIVE, GOLETA CA 93117 |
| Brenton Taylor |
officer: Vice President, Engineering |
326 BOLLAY DRIVE, GOLETA CA 93117 |
| Elizabeth Mora |
director |
C/O MKS INSTRUMENTS, INC., 2 TECH DRIVE, SUITE 201, ANDOVER MA 01810 |
| George J Parr |
director |
BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417 |
| Byron Myers |
officer: Vice President, Marketing |
326 BOLLAY DRIVE, GOLETA CA 93117 |
Inogen (Inogen) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
INGN has been successfully added to your